Japanese drugmaker Takeda, a frequenter of the China import expo, has experienced business expansion since its inaugural participation in the expo in 2018.
Now, its Chinese subsidiary has developed into one of the best-performing transnational pharmaceutical firms in China.
Produced by Xinhua Global Service
